[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-359230-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-359230-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","short-chain-acyl-coa-dehydrogenase-initiates-mtdna-demethylation-and-leakage-to-fuel-antitumor-immunity-in-colorectal-cancer","Short-chain acyl-CoA dehydrogenase initiates mtDNA demethylation and leakage to fuel antitumor immunity in colorectal cancer","","Short-chain acyl-CoA dehydrogenase (ACADS) is aberrantly deficient in colorectal cancer (CRC) and correlates with disease progression in patients. ACADS loss promotes tumor growth by coordinating a cGAS–STING signaling-dependent immunosuppressive tumor microenvironment in xenograft and AOM/DSS models. Mechanistically, ACADS suppresses cGAS–STING activity by inhibiting mitochondrial mtDNA leakage in a nonmetabolic manner through binding and blocking mito-DNMT1-dependent mtDNA methylation, stabilizing mtDNA. Restoring mito-DNMT1 via genetic or pharmacological approaches rescues mtDNA leakage, signaling, and CRC progression. Hypericin, an ACADS-binding compound, upregulates ACADS, mimics ACADS pathway activation, improves immune microenvironment, and suppresses CRC growth.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/short-chain-acyl-coa-dehydrogenase-initiates-mtdna-demethylation-and-leakage-to-fuel-antitumor-immunity-in-colorectal-cancer/359230/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/short-chain-acyl-coa-dehydrogenase-initiates-mtdna-demethylation-and-leakage-to-fuel-antitumor-immunity-in-colorectal-cancer/359230.png","ImageObject",300,407,{"name":42,"@type":43},"Rhys","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does ACADS play in colorectal cancer progression?","Question",{"text":63,"@type":64},"ACADS is abnormally deficient in CRC cells and its loss is associated with cancer progression in human patients. Ablation of ACADS promotes CRC progression by shaping an immunosuppressive tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does ACADS regulate the cGAS–STING pathway?",{"text":68,"@type":64},"ACADS deficiency suppresses cGAS–STING signaling by inhibiting mitochondrial mtDNA leakage in a nonmetabolic manner. This occurs through binding and inhibiting mito-DNMT1-dependent mtDNA methylation, which stabilizes mtDNA and reduces leakage.",{"name":70,"@type":61,"acceptedAnswer":71},"How can mito-DNMT1 and hypericin restore antitumor immune signaling?",{"text":72,"@type":64},"Genetic or pharmacological modulation of mito-DNMT1 restores ACADS-regulated mtDNA leakage, cGAS–STING signaling, and CRC progression. Hypericin binds ACADS, upregulates ACADS expression, mimics ACADS overexpression-regulated pathways, improves the immune tumor microenvironment, and suppresses CRC growth.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},359230,1790520704,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Signal Transduction [and Targeted Therapy](and Targeted Therapy www.nature.com/sigtrans)[ www.nature.com/sigtrans](and Targeted Therapy www.nature.com/sigtrans)  \nShort-chain acyl-CoA dehydrogenase initiates mtDNA demethylation and leakage to fuel antitumor immunity in colorectal cancer  \nFang Yang 1,2,3,4, Meng Wang 1,2,4, Shaofan Hu1,2,4, Xu Guan5,6, Kun Zhao 1,4, Yong Zhou7, Hui Yao2,8, Tianying Zhang 1,2,4, Liuli Li1,2,4, Yuan Gao 1,4, Sijie Zhao 1,4, Nan Liu1,4, Weidong Xiao 9, Yuancai Xiang 8 ✉ and Hongming Miao 1,2,4 ✉  \n\n| | Reprogramming of lipid metabolism and cyclic GMP‒AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling is associated with cancer development. However, whether and how fatty acid metabolism regulates the cGAS‒STING pathway in colorectal cancer (CRC) remains to be elucidated. In this study, we found that short-chain acyl-CoA dehydrogenase (ACADS) is aberrantly deﬁcient in CRC cells and is associated with cancer progression in human patients. We further revealed that ablation of ACADS promoted CRC progression by orchestrating the cGAS‒STING signaling-dependent immunosuppressive tumor microenvironment (TME) in mouse xenografts and AOM/DSS-induced CRC models. Mechanistically, ACADS deﬁciency suppressed cGAS‒STING signaling by inhibiting mtDNA leakage in a nonmetabolic manner. ACADS binds to and inhibits mitochondrial DNMT1 (mito-DNMT1)-dependent mtDNA methylation, thereby stabilizing mtDNA and inhibiting its leakage. Genetic and pharmacological modulation of mito-DNMT1 restored ACADS-regulated mtDNA leakage, cGAS‒STING signaling, and CRC progression. Importantly, strong correlations between ACADS, mito-DNMT1, and STING signaling and the immune TME were found in patients with CRC. Furthermore, we screened and identiﬁed an old drug, hypericin, as an ACADS-binding compound that upregulates ACADS expression. Hypericin treatment can mimic ACADS overexpression-regulated pathways, ultimately improving the immune TME and suppressing CRC growth. These ﬁndings highlight a previously undiscovered ACADS/mito-DNMT1 complex that links fatty acid | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | metabolism reprogramming to mtDNA methylation and cGAS‒STING signaling-dependent antitumor immunity. |  |\n|  |  |  |\n|  |  |  |\n|  | Signal Transduction and Targeted Therapy (2026)11:113 ; [https://doi.org/10.1038/s41392-026-02675-8](https://doi.org/10.1038/s41392-026-02675-8) |  |\n|  |  |  |\n\nINTRODUCTION  \nColorectal cancer (CRC) is among the most prevalent cancers worldwide, with an estimated more than 1.92 million new cases and 903 thousand deaths occurring in 2022, ranking third in incidence and second in mortality.1 Distant metastasis, involving the lymph nodes, liver, lung, and peritoneum, is the leading cause of death in most patients with CRC, with a 5-year survival rate of less than 20% .2 Currently, prevalent strategies for the treatment of CRC encompass multimodal-combined approaches that include surgery, radiotherapy, and chemotherapy; however, the rates of recurrence and metastasis remain notably high.3,4 In recent years, immunotherapy has demonstrated great potential for cancer treatment, whereas only a minor number of strong immuneactivated CRC patients with microsatellite instability-high ordeﬁcient mismatch repair are beneﬁt for it.4 Therefore, elucidating the underlying mechanisms by which CRC cells inhibit the immune microenvironment and evade immune surveillance,  \nalong with developing these novel target-based strategies, represents a critical focus for enhancing progression-free survival in patients with various types of CRC.  \nMetabolic reprogramming is an important feature and material basis of solid tumors such as CRC. This reprogramming involves altered expression and activity of metabolic enzymes, leading todysregulated metabolite levels.5 Many studies suggest that","cbCaifqAR2ZqV8Oi","https://ap.wps.com/l/cbCaifqAR2ZqV8Oi","pdf",10337713,21,"English","# Introduction\n## Colorectal cancer burden and immunotherapy limitations\n## Metabolic reprogramming and nonmetabolic metabolic enzyme roles\n## Lipid metabolism remodeling in CRC malignancy","[{\"question\":\"What role does ACADS play in colorectal cancer progression?\",\"answer\":\"ACADS is abnormally deficient in CRC cells and its loss is associated with cancer progression in human patients. Ablation of ACADS promotes CRC progression by shaping an immunosuppressive tumor microenvironment.\"},{\"question\":\"How does ACADS regulate the cGAS–STING pathway?\",\"answer\":\"ACADS deficiency suppresses cGAS–STING signaling by inhibiting mitochondrial mtDNA leakage in a nonmetabolic manner. This occurs through binding and inhibiting mito-DNMT1-dependent mtDNA methylation, which stabilizes mtDNA and reduces leakage.\"},{\"question\":\"How can mito-DNMT1 and hypericin restore antitumor immune signaling?\",\"answer\":\"Genetic or pharmacological modulation of mito-DNMT1 restores ACADS-regulated mtDNA leakage, cGAS–STING signaling, and CRC progression. Hypericin binds ACADS, upregulates ACADS expression, mimics ACADS overexpression-regulated pathways, improves the immune tumor microenvironment, and suppresses CRC growth.\"}]","Short-chain acyl-CoA dehydrogenase initiates mtDNA demethylation and leakage to fuel antitumor immunity in colorectal cancer | PDF",1790136473,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b68a719a87a5c9577d263d2403039f5.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9ea1d0468acfdf6e05158c909044780.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d9bef047cf0e64d8e66859147d1766d.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e9a62f6563bdf2b641700ac627cdfaf.webp",980,1301]